id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2002-D-0094-0004,FDA,FDA-2002-D-0094,"Guidance for the Public, FDA Advisory Committee Members, and FDA Staff: Public Availability of Advisory Committee Members' Financial Interest Information and Waivers; Availability",Notice,NAD-Notice of Availability of Data,2008-08-05T04:00:00Z,2008,8,2008-08-05T04:00:00Z,,2024-11-12T04:15:49Z,E8-17999,1,0,09000064806aed88
FDA-2002-D-0094-0005,FDA,FDA-2002-D-0094,"Guidance for the Public, FDA Advisory Committee Members, and FDA Staff:  Public Availability of Advisory Committee Members' Financial Interest Information and Waivers, August 2008",Other,GDL-Guidance (Supporting and Related Materials),2008-08-05T04:00:00Z,2008,8,2008-08-05T04:00:00Z,,2010-08-06T23:48:05Z,,0,0,09000064806af63a